Free Newsletter
Woman's immune system may be key to HIV vax
An investigative team at Johns Hopkins has been studying a woman whose natural immunity has quelled the virus she was infected with 10 years ago. Researchers say that she is an 'elite suppressor:' her immune cells could hold the key to solving the vexing riddle of creating a vaccine for HIV.
"This is an extremely rare case of co-infection in a controlled, monogamous relationship, which showed us how a strong immune system in the elite suppressor kept the virus from replicating and infecting other cells," said Joel Blankson, the senior study investigator and infectious disease specialist.
The woman's CD-8 T cells were able to stall roughly 90 percent of HIV replication, a duplicate of the virus that affects her husband. The researchers want to learn what kind of cytokines--immune system signaling proteins--are made by her T cells. They are also interested in learning more about why they're seeing odd activity in her human leukocyte antigen system.
- check out the press release
Related Articles:
HIV research summit seeks new discovery path
Feds steering funds back to basic AIDS vax research
AIDS scientist backed on new vaccine approach
Fauci says HIV vaccine requires a new approach
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


